Objective To analyze and study the effect of the case XNJI acute cerebral hemorrhage for clinical treatment. Methods Choose to take in June 2009 - June 2015, our department in the diagnosis and treatment of 200 cases of acute cerebral hemor-rhage. Divided according to their average treatment time of admission into the control group and the observation group two (n=100 cases of patients each) were used to conventional therapy and XNJI clinical treatment, and compared two groups of patients and statistical analysis The clinical effectiveness of treatment. Results The statistical comparison showed that patients in the observa-tion group after treatment neurological deficit scores(8.1±3.2) was significantly lower than the control group of patients (12.3±4.0), total clinical efficiency (92.0%) was significantly higher in patients (81.0%), the two groups significant differences are statistically significant (P<0.05). Adverse reaction rates (1.0%) is slightly higher than the observation group were patients (0), but the results were not significant, there was no significant (P>0.05). Conclusion XNJI acute cerebral hemorrhage clinical treatment, the effect is significant, recovery of neurological function in patients with ideal, fewer adverse reactions, therefore, it is an effective and safe, ideal, clinical scientific method.%目的 分析和研究采用醒脑静注射液对急性脑出血患者进行临床治疗的效果情况. 方法 随机择取 2009年6月—2015年6月以来, 在该院进行诊治的200例急性脑出血患者. 将他们根据入院就诊时间平均划分成对照组和观察组两组(每组患者100例),分别采用常规疗法和醒脑静注射液进行临床治疗,将两组患者的临床治疗情况和效果进行对比分析.结果 观察组患者临床治疗后的神经功能缺损评分(8.1±3.2)明显低于对照组患者(12.3±4.0),而观察组的临床总有效率(92.0%)与对照组患者(81.0%)相比明显较高,两组比较差异有统计学意义(P<0.05). 观察组患者的不良反应率(1.0%)略高于对照组患者(0),但比较结果差异无统计学意义(P>0.05).结论 采用醒脑静注射液对急性脑出血患者进行临床治疗,其疗效显著,患者神经功能恢复理想,不良反应少,因此,它是一种有效、安全、理想、科学的临床治疗方法.
展开▼
